Wheres can this UPI article be found that everyone keeps referring to??
The Drudge report times out.
Melbourne biopharma Opthea will abandon a second major clinical trial into the treatment of wet, age-related macular degeneration, a week after revealing a trial into its flagship compound sozinibercept had failed.